chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When I received my first injection on 06/03/2021, I experienced fatigue and arm soreness for about three days, which was to be expected.  After receiving my second vaccine on 06/30/2021, my health has been rather poor. I?ve been extremely fatigued and have been experiencing heart palpitations for the last week and a half - which is why I visited my physician. They ran a tremendous amount of bloodwork - to which it appears that the Epstein Barr Virus has been reactivated.  Also of concern, I had an echocardiogram and my pulmonic valve, for the first time, is showing a trace insufficiency. I had an echocardiogram prior to my vaccine and it showed no such issue.
Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Janssen Vaccine (Batch number- 1808980) on 05-May-2021. Past adverse reactions to the above products included No adverse event with Janssen Vaccine.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient's weight was unknown. It was reported that the patient received Moderna Covid-19 vaccine that underwent a temperature excursion. The temperature excursion was not known of at the time of administration of the vaccine. The temperature excursion was found out about after a review of the temperature datalogger on the refrigerator that the Moderna Covid-19 vaccine was stored in. The Nurse has used the online Temperature excursion tool and was comfortable that her patient dose was valid and that the affected vaccine was viable for future doses. Side effects after any doses was unknown. No treatment medications were reported.
Headache, Myalgia, Fever,  soreness at site Narrative:  Other Relevant History:
Patient received IM dose and was advised to stay in waiting area for 15 minutes: he left area and went to see if ride  was there to pick him up; he fell and sustained several lacerations on head and left knee. EMS came and provided bandage and verbally assessed patient. He decided to leave with friend. No additional info was provided and patient later informed me that he saw Dr and no additional treatment as needed
Covid monitoring documentation. PT admitted 1/6/22 documented to have positive covid. PT received Moderna 1/29/21 Lot 012L20A for dose 1. Dose 2 was Moderna given on 2/26/21 Lot 022M20A.
h/a, lightheaded, difficulty focusing eyes, felt like burning up inside, chest pressure, achy joints (elbows/knees), diaphoresis, dry mouth;
Presented to ED with chest pain 4/27/2021, mildly elevated troponin 0.066, peaked at 0.165,  demonstrated normal biventricular function,  coronary angiography demonstrated normal coronary arteries,  5/27/2021 demonstrated normal biventricular function but delayed hyperenhancement revealed localized pericardial and subepicardial hyperenhancement consistent with Myopericarditis
3rd dose of Moderna (booster) given early. Patient received dose #1 on 9/8/21, dose #2 on 10/7/21, and dose #3 (booster) on 11/11/21 (~5 months early)
No additional adverse effects reported; expired product used; This spontaneous report as received from a nurse and refers to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 13-AUG-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)  (dose, frequency, route and vaccination site were not provided), for prophylaxis that was reconstituted with expired diluent (lot# reported as "N030411", expiration date  04-JUL-2020, on 13-AUG-2020.
Pt reports feeling very weak and tired, rested for awhile. 1730 pt reports feeling dizzy and heart racing to the point she was unable to sit up, chills fever of 100.3, sore arm with redness and warmth. Discomfort in the arm pit.  At 2130 pt called the ER and took some Tylneol for fever. Symptoms continued until 8/29, temp down to 99.  On 8/30 pt was seen by personal MD.
Days after the flu shot I started feeling very tired. On 11/12/19 i noticed my hands and feet numb and tingling . On 11/14/19 I started getting a pounding headache. The week of 11/17/19 to 11/23/19 I started getting weaker by the day to the point where i needed help to get in and out of bed, standing and walking and going to the bathroom i was only able to take baby steps i couldn?t even stand to brush my teeth. I fell twice trying to walk on my own. I was breastfeeding and my milk supply completely dried up.  On 11/25/19 I was diagnosed with Guillain Barre Syndrome and was treated on 11/27/19 - 12/1/19 with Immune Globulin Intravenous
So basically at the seventh of July 2021, I had a pinkish red discharge. Then after the bleeding stopped there was some brownish discharge and I went to the doctor, the doctor monitored me on July 8th, 2021, checking baby's heart and movement. They also checked my vagina and cervix to confirm there was no more bleeding at that time. They said I was okay and they not concerned about it. They also did a test of my urine and found nothing abnormal. I was at the doctor approximately three hours. This is my first child so I have not had any others. My date of delivery is September 21, 2021. The doctor I saw was a certified NP.
13 days after receiving the second dose of the Moderna COVID vaccine, a large very hot, hard, and a tender red lump appeared at the vaccination site. There was some initial swelling and tenderness immediately following the vaccine for about 3 days and then it went away. It returned then on day 13, accompanied by pain and discomfort in the right arm. The lump was approximately 4 inches in diameter and swelled about an inch out from the surrounding skin
Pt had immunizations on 04/25/05. Edema/redness to left arm to elbow on 04/26. Seen 04/27/05 at clinic. F/U on 04/28. TX: cold compresses, Tylenol, and Benadryl.
Itchiness w tiny red dots appearing randomly on body (mostly torso, breasts, upper arms, behind knees) began a few weeks after shot, saw three doctors - no real diagnosis given. Prescription ointment and hydroxyzine hcl. Also told what to use for showers which might be helpful, nothing is getting rid of this so far. Was told only that my nerve endings were being irritated.
Red itchy rash and hives around knees, ankles, and upper arms. Treated with claritin, liquid Benadryl, skin cream with  Benadryl and skin cream with 1% cortizone. Returned again each evening for 5 days.   Never experienced this before. Happened over 2 weeks after receiving Moderna COVID19 booster.
Day after her shot, patient's mother called to report leg was hot and swollen. Patient became worse and came in 24 hours later. Her leg was massively swelling, red, and indurated. ? cellulitis to Prevnar. Rx with 500mg Rocephin IM and 600mg Augmentin.  Follow up 1 day later, reduced swelling and induration. Follow up 10/7/02 - complete resolution of swelling, redness, and induration.
During a flu vaccine clinic for employees of Behavioral Services at the Treatment Center, this employee was inadvertently given expired influenza vaccine.  The vaccine administered was for the 2021-2022 season and expired on 6/30/2022.  The employee was made aware of the this mistake, did not present with any adverse clinical reaction, and will be administered the influenza vaccine for the 2022-2023 season as soon as clinically appropriate.
Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.  Date the vial was initially stored in the refrigerator was 17Dec2021.
drowsiness and he couldn't stay awake; This is a spontaneous report from a contactable consumer (Patient). A 58-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 26Apr2021 as 1st dose, single dose for covid-19 immunisation. Medical history included narcolepsy [use of Adderall (amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate), and use of generic Adderall for "at least 15 years" (relative to 21May2021)]. Concomitant medications included vitamin d nos (VITAMIN D NOS); omeprazole (OMEPRAZOLE; for 10 to 20 years); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for narcolepsy and daily vitamins. On 03May2021, Patient had slept for 4 days since starting it, also described as drowsiness and he couldn't stay awake. He thought there might be a tiny chance the drowsiness could be from the COVID vaccine, but he thought if the drowsiness was from the vaccine it would not last as long as it had. The drowsiness and being unable to stay awake were ongoing, as he had "slept for almost 3 weeks". On 17May2021, patient received his second dose of the COVID vaccine. The outcome of events was not recovered.   Information about batch/Lot number has been requested.
In three hours to taking the shot she was feeling nausea and she went to sleep. She woke up at 5 p.m with sore throat and cough followed by fast breathing. Our primary care is closed now but if her conditions worsens we will take her to Emergency.
PSORIASIS ON SCALP AND ELBOWS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced psoriasis on scalp and elbows. The action taken with covid-19 vaccine was not applicable. The outcome of psoriasis on scalp and elbows was not reported. This report was non-serious.
Information has been received form a RN concerning a 2nd grade male student who on 10/27/1997was vaccinatded with a dose of varicella virus vaccien lie. In mid Decembe the child  developed Chickenpox in mid December of 2004. According to the school nurse 58 other elementary school students who developed chicken pox and 34 of them had previously been vaccinated with a dose of varicella virus vaccine live. Unspecified medical attention was sought. There was no information regarding the present status of the student. No product quality complaint was involved.  Addition information    has been requested.
After 30 minute observation period, pt. remoed her bandaid and stated she had a slight itching at the injection site.  Slight redness noted, but pt. had been scratching.  No swelling.  Denied any other symptoms and states has had allergic reactions before and this didn't feel like one.  Pt. was instructed to go to the ED if she had any worsening or concerning symptoms.  Pt. verbalized understanding.
Chest pains, shortness of breath, racing heart, fatigue, weakness.  Being treated for Pericarditis  Medications - Colchicine , Asprin , Famotidine
Received vaccine on 12/28/2020 and c/o jitteriness on 12/29/2020 and dizziness with jitteriness on 12/30/2020. BP 152/83 HR 78. States he felt like he was floating when walking to his car this morning
This spontaneous report as received from a pharmacist refers to a 71 year old female patient. The patient had no pertinent medical history and no drug reactions/allergies. On 25-OCT-2013 the patient was vaccinated with PNEUMOVAX23 lot # H021941, exp 11-JUL-2014 intramuscular in the arm. Pharmacist reported that the site in which the PNEUMOVAX23 was administered was on the inner aspect of the upper arm, not the deltoid. Pharmacist further reported that after receiving the vaccination, patient developed redness and soreness at the injection site (onset date was 25-OCT-2013). Treatment was TYLENOL. No labs were performed. The was unknown. Additional information has been requested.
Tongue swelling, coughing, treated with Benadryl and Epi - patient transported to the ER
3-6 hrs right arm red, warm, swollen and limp. 24 hrs headaches, malaise, throbbing pain right arm. 8/22/05 had increased temp for 72. So much improved. Site continues to be "tender".
The patient reports that the day following her 2nd vaccination  she developed a fever (lasting 48 hrs) up to 101.1F, headache, abdominal cramps, nausea, diarrhea and numerous sores in her mouth.
fever & rash 11/9/99 p/vax on 10/26/99
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 51-year-old male patient who received SHINGRIX. Concurrent medical conditions included penicillin allergy. Concomitant products included vitamin d, magnesium, TURMERIC and zinc. On 3rd May 2018, the patient received the 1st dose of SHINGRIX. On 4th May 2018, 1 days after receiving SHINGRIX, the patient experienced pain in arm, feeling abnormal, fatigue and headache. On an unknown date, the outcome of the pain in arm, feeling abnormal, fatigue and headache were not recovered/not resolved. The reporter considered the pain in arm to be probably related to SHINGRIX. The reporter considered the feeling abnormal, fatigue and headache to be possibly related to SHINGRIX. Additional details were reported as follows: The patient's concomitant medications included unspecified supplements. The patient received SHINGRIX in the left deltoid. The patient felt blah (feeling abnormal).
Grad student states that she continues to experience daily muscle twitches (brief- lasting 2 to 3 seconds) mainly noticed when she is still; she feels this on various muscles of her body- more lower than upper(calf, left foot, thighs, buttock, cheek, scalp, eyelids from 5 to 25 times/day; She first noticed this about 5 weeks after she got her first Hep B vaccine (also given MMR and Tdap that same day); She then received her 2nd Hep B vaccine on 11/13/2015.
Patient experienced inflammation around the injection site and it was very red and hot to touch. Area cover shoulder and patient complained of fever as well.
This spontaneous report as received from a nurse practitioner via field representative refers to a 61 year old female patient with allergy rhinitis, gastroesophageal reflux disease (GERD). Allergies included pseudoephedrine; BUPROPION; methylprednisone; NORCO; PERCOCET; FENTENYL, DILAUDID, erythromycin, methylprednisone, codeine, VERSED, MIDOL and caffeine. On 21-JUL-2014 the patient was vaccinated with ZOSTAVAX lot # J014812, expiration date:20-FEB-2015, 0.65 ml in the left arm (strength and route unknown). On 21=JUL-2014, the patient experienced severe pain, blisters and redness around the injection site. It was also reported that on that day, post vaccination, the red vesicular rash occurred, vesicular rash and erythema extending elbow to axilla with multiple blisters at injection site. The patient visited the office on unspecified date. The outcome of the events was reported as recovered on 28-JUL-2014, reported as healing. The patient did not have recent VZV exposure to chickenpox or shingles. Additional information has been requested.
Beginning at 11 p.m. I had violent vomiting approximately every 20 to 30 minutes until 4 a.m.  Because I continued to vomit only bile, I took a 1 mg Lorazepam left over from a hospital visit for a broken wrist. This calmed things enough to allow me to finally fall asleep at about 4:30 a.m.  Red splotches broke out on my forehead and I continue to have some to this day.
Information has been received from a 60 year old female consumer via a company representative concerning herself. The patient's concurrent conditions, medical histories and concomitant therapies were not provided. On the patient's 60th birthday (date unspecified), the patient was vaccinated a dose of ZOSTAVAX (lot #, expiration date, dose and route were unknown). Then the patient developed a pretty bad reaction in her arm, which included swelling and redness which lasted for weeks (date unspecified). At the time of reporting, the outcome of the events was not provided. No product quality complaint (PQC) was involved. The causal relationship between the events and ZOSTAVAX was not provided. Additional information has been requested.
Fatigue beginning 24 hours after vaccine admin.  Fever 101-104.5 24-36 hours after vaccine.  Nausea, lightheadedness walking up stairs 24-36 hours after.  Erythema & induration of injection site 3 days later.
Information has been received from a health professional concerning an 8 yr old white male with no known history or allergies who on 25Mar99 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live (lot 628522/1843H). On 03Feb06 the pt was seen by the physician with an itchy rash on his back, bottom and feet which started within the last week. The physician diagnosed the pt with a breakthrough case of chickenpox. It was reported that the pt was still breaking out in lesions. There was no product quality complaint involved. Follow up information indicated that the pt subsequently recovered. No further information is available.
experienced fatigue after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (experienced fatigue after the 2nd dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure high and High cholesterol. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), CLONIDINE and AMLODIPINE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (experienced fatigue after the 2nd dose). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) for Adverse event, at a dose of 1 tab twice daily from the emergency room. At the time of the report, FATIGUE (experienced fatigue after the 2nd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-385894 (Patient Link).
Received H1N1 injection to left deltoid. Had muscle soreness but pain radiated to neck area; also c/o "burning" sensation to shoulder and neck area. Warm compresses to area and aspirin for pain. Rates pain "*" from 0-10 scale.
Eczema, balanitis. Eczema not resolved, got worse after second shot, itchy red blotches on forearms, inside of thighs, lower neck , stomach a little on calves. Sometimes wake up at night with severe itching. Balanitis, took 150 mg. Fluconazole, applied  antifungal medications and improved. I took second shot March 03.
Pt developed pain/swelling along the length of arm to the fingertips over the course of a couple days. The pain was causing difficulty sleeping on affected arm, and it made it difficult for her to drive/lift her arm. She began taking Benadryl and Motrin which resolved the issue.  She returned to the pharmacy on 11/21/16 to inform us of what happened and said that the  pain/swelling has resolved.
Pt received vaccine on 7 jan. 2021   Twelve days later, on 19 January 2021, Pt developed symptoms of COVID (cough, sore throat, fever, myalgias), on 20 Jan, pt admitted to hospital for worsening symptoms. Pt tested positive for COVID 19.  Pt admitted to ICU where pt had complicated hospital course to include ARDS secondary to COVID pneumonia, nonSTEMI, with biventricular heart failure, on  multiple pressor,  rhabdomyolysis with acute kidney injury, requiring CRRT.   Pt was in hospital for 10 days; he passed away on 31 Jan 2021.
Patient initially experienced headache, body aches, arm pain, and swelling under the armpits. Patient managed symptoms with ice packs. Symptoms have resolved as of 1/6/2021